Maggot therapy for wound debridement: A randomized multicenter trial

Archives of Dermatology

Volumn 148, Issue 4, 2012, Pages 432-438

  Opletalová, Kristina ^a   Blaizot, Xavier ^a   Mourgeon, Bénédicte ^a   Chêne, Yannick ^a   Creveuil, Christian ^a   Combemale, Patrick ^b   Laplaud, Anne Laure ^a   Sohyer Lebreuilly, Ingrid ^a   Dompmartin, Anne ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b HIA Desgenettes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAGGOT THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVER VARIATION; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN EXFOLIATION; THERAPY EFFECT; WOUND; WOUND DRESSING; WOUND HEALING;

AGED; AGED, 80 AND OVER; ANIMALS; ANKLE BRACHIAL INDEX; CHI-SQUARE DISTRIBUTION; DEBRIDEMENT; FEMALE; HUMANS; LARVA; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SINGLE-BLIND METHOD; STAPHYLOCOCCAL INFECTIONS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84859956547     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.1895     Document Type: Article

References (32)

1. Beitz JM. Wound debridement: therapeutic options and care considerations. Nurs Clin North Am. 2005;40(2):233-249. (Pubitemid 40744983)
2. Steed DL. Debridement. Am J Surg. 2004;187(5)(suppl 1):71S-74S. (Pubitemid 38625991)
3. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(suppl 1):S1-S28. (Pubitemid 36514829)
4. Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen. 2005;13 (2):131-137. (Pubitemid 40489862)
5. Cardinal M, Eisenbud DE, Armstrong DG, et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen. 2009;17(3):306-311.
6. Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts:mechanism for wound healing by maggot therapy. Life Sci. 1997;60(8):505-510. (Pubitemid 27099797)
7. Chambers L, Woodrow S, Brown AP, et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol. 2003; 148(1):14-23. (Pubitemid 36114856)
8. Schmidtchen A, Wolff H, Rydengård V, Hansson C. Detection of serine proteases secreted by Lucilia sericata in vitro and during treatment of a chronic leg ulcer. Acta Derm Venereol. 2003;83(4):310-311.
9. van der Plas MJ, Jukema GN, Wai SW, et al. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 2008;61(1):117-122.
10. Gericke A, Pitz S. Maggot therapy for periocular skin graft failure in the immunocompromised patient. Br J Ophthalmol. 2008;92(6):860-861. (Pubitemid 351839585)
11. van Veen LJ. Maggot debridement therapy: a case study. J Wound Ostomy Continence Nurs. 2008;35(4):432-436.
12. Nordström A, Hansson C, Karlström L. Larval therapy as a palliative treatment for severe arteriosclerotic gangrene on the feet. Clin Exp Dermatol. 2009;34 (8):e683-e685. doi:10.1111/j.1365-2230.2009.03405.x.
13. Mumcuoglu KY, Ingber A, Gilead L, et al. Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care. 1998;21(11):2030-2031. (Pubitemid 28478316)
14. Sherman RA, Wyle F, Vulpe M. Maggot therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med. 1995;18(2):71-74.
15. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002;10(4):208-214. (Pubitemid 35006781)
16. Laplaud AL, Blaizot X, Gaillard C, et al. Wound debridement: comparative reliability of three methods for measuring fibrin percentage in chronic wounds. Wound Repair Regen. 2010;18(1):13-20.
17. Wolff H, Hansson C. Larval therapy-an effective method of ulcer debridement. Clin Exp Dermatol. 2003;28(2):134-137. (Pubitemid 36459614)
18. Mumcuoglu KY, Ingber A, Gilead L, et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol. 1999;38(8):623-627. (Pubitemid 29404797)
19. Fleischmann W, Russ M, Moch D, Marquardt C. Biosurgery-maggots, are they really the better surgeons? Chirurg. 1999;70(11):1340-1346.
20. Cartier E, Combemale P. Maggot therapy with Lucilia sericata for debridement of chronic wounds. Ann Dermatol Venereol. 2008;135(10):685-688.
21. Dumville JC, Worthy G, Bland JM, et al; VenUS II team. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ. 2009;338:b773. doi:10.1136 /bmj.b773.
22. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in-vivo results. J Tissue Viability. 2004;14(3):97-101.
23. Cazander G, van Veen KE, Bernards AT, Jukema GN. Do maggots have an influence on bacterial growth? a study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions. J Tissue Viability. 2009;18(3):80-87.
24. Andersen AS, Joergensen B, Bjarnsholt T, et al. Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots. Microbiology. 2010;156(pt 2):400-407.
25. Cazander G, van Veen KE, Bouwman LH, Bernards AT, Jukema GN. The influence of maggot excretions on PAO1 biofilm formation on different biomaterials. Clin Orthop Relat Res. 2009;467(2):536-545.
26. Sibbald RG, Orsted HL, Coutts PM, Keast DH. Best practice recommendations for preparing the wound bed: update 2006. Adv Skin Wound Care. 2007;20 (7):390-405.
27. Ayello EA, Cuddigan JE. Debridement: controlling the necrotic/cellular burden. Adv Skin Wound Care. 2004;17(2):66-75.
28. Waite A, Gilliver SC, Masterson GR, Hardman MJ, Ashcroft GS. Clinically relevant doses of lidocaine and bupivacaine do not impair cutaneous wound healing in mice. Br J Anaesth. 2010;104(6):768-773.
29. Nykanen D, Kissoon N, Rieder M, Armstrong R. Comparison of a topical mixture of lidocaine and prilocaine (EMLA) versus 1% lidocaine infiltration on wound healing. Pediatr Emerg Care. 1991;7(1):15-17.
30. Petherick ES, O'Meara S, Spilsbury K, Iglesias CP, Nelson EA, Torgerson DJ. Patient acceptability of larval therapy for leg ulcer treatment: a randomised survey to inform the sample size calculation of a randomised trial. BMC Med Res Methodol. 2006;6:43. doi:10.1186/1471-2288-6-43.
31. Grassberger M, Fleischmann W. The Biobag-a new device for the application of medicinal maggots. Dermatology. 2002;204(4):306. doi:10.1159 /000063372.
32. Blake FA, Abromeit N, Bubenheim M, Li L, Schmelzle R. The biosurgical wound debridement: experimental investigation of efficiency and practicability. Wound Repair Regen. 2007;15(5):756-761. (Pubitemid 47493899)